Altimmune (ALT) Preferred Shares (2016)

Altimmune (ALT) reported Preferred Shares of $5993.0 for Q4 2016.

Altimmune (ALT) Preferred Shares (2016) Analysis & Trends

Altimmune (ALT) has 1 years of Preferred Shares data on file, last reported at $5993.0 in Q4 2016.

Preferred Shares for Q4 2016 came in at $5993.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2016 was $5993.0 (changed N/A YoY), and the FY2016 annual result was $5993.0, changed N/A from the prior year.
Preferred Shares was little changed at $5993.0 in Q4 2016 per ALT's latest filing.
Over five years, Preferred Shares peaked at $5993.0 in Q4 2016 and troughed at $5993.0 in Q4 2016.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Altimmune	336.67 Mn	336.67 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2016	5,993.00